EP3950934A4 - Verfahren zur züchtung einer zellpopulation und verwendung davon - Google Patents

Verfahren zur züchtung einer zellpopulation und verwendung davon Download PDF

Info

Publication number
EP3950934A4
EP3950934A4 EP20778085.9A EP20778085A EP3950934A4 EP 3950934 A4 EP3950934 A4 EP 3950934A4 EP 20778085 A EP20778085 A EP 20778085A EP 3950934 A4 EP3950934 A4 EP 3950934A4
Authority
EP
European Patent Office
Prior art keywords
cell population
culturing cell
culturing
population
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20778085.9A
Other languages
English (en)
French (fr)
Other versions
EP3950934A1 (de
Inventor
Daisuke Sakai
Yoshihiko Nakamura
Erika Matsushita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Tokai University Educational Systems
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Tokai University Educational Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd, Tokai University Educational Systems filed Critical Nippon Zoki Pharmaceutical Co Ltd
Publication of EP3950934A1 publication Critical patent/EP3950934A1/de
Publication of EP3950934A4 publication Critical patent/EP3950934A4/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/32—Polylysine, polyornithine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
EP20778085.9A 2019-03-25 2020-03-25 Verfahren zur züchtung einer zellpopulation und verwendung davon Pending EP3950934A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019012571 2019-03-25
PCT/JP2020/013307 WO2020196615A1 (ja) 2019-03-25 2020-03-25 細胞集団の培養方法及びその利用

Publications (2)

Publication Number Publication Date
EP3950934A1 EP3950934A1 (de) 2022-02-09
EP3950934A4 true EP3950934A4 (de) 2022-12-28

Family

ID=71103931

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20778085.9A Pending EP3950934A4 (de) 2019-03-25 2020-03-25 Verfahren zur züchtung einer zellpopulation und verwendung davon

Country Status (11)

Country Link
US (1) US20220056418A1 (de)
EP (1) EP3950934A4 (de)
JP (2) JP6712740B1 (de)
KR (1) KR20210153066A (de)
CN (1) CN113874489A (de)
AU (1) AU2020244911A1 (de)
BR (1) BR112021019037A2 (de)
CA (1) CA3134256A1 (de)
IL (1) IL286558A (de)
SG (1) SG11202110461UA (de)
WO (1) WO2020196615A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114591900B (zh) * 2022-03-18 2022-10-18 河北北冥生物科技有限公司 一种提高干细胞分化能力的体外培养方法及培养基和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150125542A1 (en) * 2010-12-02 2015-05-07 Maruzen Pharmaceuticals Co., Ltd. TIE2 Activator, Vascular Endothelial Growth Factor (VEGF) Inhibitor, Angiogenesis Inhibitor, Vascular Maturing Agent, Vascular Normalizing Agent and Vascular Stabilizing Agent, and Pharmaceutical Composition

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5150824A (en) 1974-10-31 1976-05-04 Inoue Japax Res Chojakukinzokutaino hyomenshorisochi
US5252248A (en) 1990-07-24 1993-10-12 Eaton Corporation Process for preparing a base nitridable silicon-containing material
US6723335B1 (en) * 2000-04-07 2004-04-20 Jeffrey William Moehlenbruck Methods and compositions for treating intervertebral disc degeneration
JP4778629B2 (ja) * 2001-04-24 2011-09-21 生化学工業株式会社 コラーゲン分解促進剤
US20030220692A1 (en) * 2002-02-09 2003-11-27 Shapiro Irving M. Preparations of nucleus pulposus cells and methods for their generation, identification, and use
WO2006138720A2 (en) * 2005-06-17 2006-12-28 Sun Uk Song Isolation of multi-lineage stem cells
JP2009506769A (ja) * 2005-09-02 2009-02-19 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 間充織幹細胞誘導方法
WO2009009020A1 (en) 2007-07-12 2009-01-15 Discgenics Human disc tissue
JP5126500B2 (ja) 2007-12-26 2013-01-23 いすゞ自動車株式会社 マーキング機能付きスパナ型トルクレンチ
ES2655487T3 (es) 2008-03-31 2018-02-20 Shiseido Company, Ltd. Extracto de canela para tratar el fotoenvejecimiento
JP5274431B2 (ja) 2009-11-11 2013-08-28 株式会社 資生堂 Ｔｉｅ２活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤
JP5143109B2 (ja) 2009-11-11 2013-02-13 株式会社 資生堂 Ｔｉｅ２活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤
JP2011102275A (ja) 2009-11-11 2011-05-26 Shiseido Co Ltd Ｔｉｅ２活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤
JP2011102273A (ja) 2009-11-11 2011-05-26 Shiseido Co Ltd Ｔｉｅ２活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤
JP2011201811A (ja) 2010-03-25 2011-10-13 Shiseido Co Ltd Ｔｉｅ２活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤
JP5863639B2 (ja) 2010-03-30 2016-02-16 学校法人東海大学 椎間板の状態に関する指標を得る方法、椎間板障害の治療または予防方法、および髄核細胞集団のポテンシャルまたは品質の評価方法
JP5926895B2 (ja) 2011-05-11 2016-05-25 株式会社 資生堂 Ｔｉｅ２活性化剤及びリンパ管安定化剤
CN102258809A (zh) * 2011-07-15 2011-11-30 中国人民解放军海军总医院 脐带华通胶间充质干细胞在制备细胞移植材料中的应用
JP6293402B2 (ja) 2012-05-18 2018-03-14 丸善製薬株式会社 Ｔｉｅ２活性化剤、血管新生抑制剤、血管の成熟化剤、及び血管の正常化剤、並びに飲食品
JP6211380B2 (ja) 2012-10-17 2017-10-11 丸善製薬株式会社 Ｔｉｅ２活性化剤、血管新生抑制剤、血管の成熟化剤、血管の正常化剤、及び血管の安定化剤
US11891626B2 (en) * 2013-03-15 2024-02-06 Discgenics, Inc. Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue
TWI679985B (zh) 2014-10-16 2019-12-21 日商三得利控股股份有限公司 含有橄欖果實萃取物的Ｔｉｅ２活化劑
CN108697812A (zh) * 2016-01-14 2018-10-23 脊核细胞有限责任公司 用于软骨细胞或软骨类型细胞再生的细胞混合物
CN106047801A (zh) * 2016-05-30 2016-10-26 深圳大学 一种髓核细胞分离纯化方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150125542A1 (en) * 2010-12-02 2015-05-07 Maruzen Pharmaceuticals Co., Ltd. TIE2 Activator, Vascular Endothelial Growth Factor (VEGF) Inhibitor, Angiogenesis Inhibitor, Vascular Maturing Agent, Vascular Normalizing Agent and Vascular Stabilizing Agent, and Pharmaceutical Composition

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHAN SCW ET AL: "Minimizing cryopreservation-induced loss of disc cell activity for storage of whole intervertebral discs", EUROPEAN CELLS AND MATERIALS, vol. 19, 1 January 2010 (2010-01-01), pages 273 - 283, XP093000535, Retrieved from the Internet <URL:https://www.ecmjournal.org/papers/vol019/pdf/v019a26.pdf> DOI: 10.22203/eCM.v019a26 *
LI XIAO-CHUAN ET AL: "Co-culturing nucleus pulposus mesenchymal stem cells with notochordal cell-rich nucleus pulposus explants attenuates tumor necrosis factor-[alpha]-induced senescence", STEM CELL RESEARCH & THERAPY, vol. 9, no. 1, 1 December 2018 (2018-12-01), XP093000244, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019307/pdf/13287_2018_Article_919.pdf> DOI: 10.1186/s13287-018-0919-9 *
SAKAI DAISUKE ET AL: "Successful fishing for nucleus pulposus progenitor cells of the intervertebral disc across species", JOR SPINE, vol. 1, no. 2, 1 June 2018 (2018-06-01), pages e1018, XP093000278, ISSN: 2572-1143, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686801/pdf/JSP2-1-e1018.pdf> DOI: 10.1002/jsp2.1018 *
See also references of WO2020196615A1 *
TEKARI ADEL ET AL: "Angiopoietin-1 receptor Tie2 distinguishes multipotent differentiation capability in bovine coccygeal nucleus pulposus cells", STEM CELL RESEARCH & THERAPY, vol. 7, no. 1, 23 May 2016 (2016-05-23), XP055796514, Retrieved from the Internet <URL:http://link.springer.com/content/pdf/10.1186/s13287-016-0337-9.pdf> DOI: 10.1186/s13287-016-0337-9 *
YAN ZHENGJIAN ET AL: "A Novel Organ Culture Model of Mouse Intervertebral Disc Tissues", CELLS TISSUES ORGANS, vol. 201, no. 1, 9 October 2015 (2015-10-09), CH, pages 38 - 50, XP093000272, ISSN: 1422-6405, Retrieved from the Internet <URL:https://www.karger.com/Article/Pdf/439268> DOI: 10.1159/000439268 *

Also Published As

Publication number Publication date
CN113874489A (zh) 2021-12-31
JPWO2020196615A1 (de) 2020-10-01
AU2020244911A2 (en) 2021-12-09
BR112021019037A2 (pt) 2021-11-30
CA3134256A1 (en) 2020-10-01
KR20210153066A (ko) 2021-12-16
EP3950934A1 (de) 2022-02-09
SG11202110461UA (en) 2021-10-28
JP6712740B1 (ja) 2020-06-24
WO2020196615A1 (ja) 2020-10-01
AU2020244911A1 (en) 2021-11-11
US20220056418A1 (en) 2022-02-24
IL286558A (en) 2021-12-01

Similar Documents

Publication Publication Date Title
EP3952419A4 (de) Verfahren und vorrichtung zur aktivierung von sekundärzellen
EP4056685A4 (de) Primäres brustepithelzellen-kulturmedium, kulturverfahren und dessen verwendung
EP3739037A4 (de) Zellkonfigurationsverfahren und -vorrichtung
EP3943586A4 (de) Zellkultursystem und zellkulturverfahren
EP3810749A4 (de) Systeme, verfahren und vorrichtung zur automatisierten kultivierung von zellen
EP4048293A4 (de) Systeme und verfahren zur zellzüchtung
EP3733833A4 (de) Gerüstmaterial für stammzellkulturen und stammzellkulturverfahren unter verwendung davon
EP3965459A4 (de) Verfahren und vorrichtung zur aktivierung einer sekundärzelle
EP3808833A4 (de) Zellkultursystem und zellkulturverfahren
EP3743121A4 (de) Zellkulturvorrichtung und -verfahren
EP3969560A4 (de) Mikrofluidische vorrichtung und verfahren zur verwendung zur zellzüchtung
EP3831926A4 (de) Zellkultursystem und verfahren zur zellmassenproduktion damit
EP3964560A4 (de) Zellkultursystem
EP4013854A4 (de) Zellkulturverfahren
EP3842521A4 (de) Zellkulturverfahren und zellkulturvorrichtung
EP3808835A4 (de) Zellkultursystem und zellkulturverfahren
EP3945815A4 (de) Kryokonservierung und zellkulturmedien
IL283007A (en) Cell culture system and method
EP3460050A4 (de) Zellzüchtungsverfahren, kulturmedium und kulturmediumkit
EP3950920A4 (de) Vorrichtung und verfahren zur zellmanipulation
EP3933377A4 (de) Zellbeobachtungssystem und zellbeobachtungsverfahren
EP3950934A4 (de) Verfahren zur züchtung einer zellpopulation und verwendung davon
EP3741838A4 (de) Zellkulturvorrichtung und zellkulturverfahren
EP3846924A4 (de) Verfahren zur kontinuierlichen zellkultur
EP3556842A4 (de) Zellkulturvorrichtung und zellkulturverfahren

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20211006

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40065730

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20221130

RIC1 Information provided on ipc code assigned before grant

Ipc: A01N 1/02 20060101ALI20221124BHEP

Ipc: A61P 19/00 20060101ALI20221124BHEP

Ipc: A61K 35/32 20150101ALI20221124BHEP

Ipc: C12N 5/0775 20100101ALI20221124BHEP

Ipc: C12N 5/077 20100101AFI20221124BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231222